GL1X · GenesisL1 explorer

MolNFT v1 · #128536 · protein

Crystal structure of the protein-kinase a catalytic subunit from criteculus griseus in complex with compound RKP032

5NTJ · Camp-dependent protein kinase catalytic subunit alpha: “Crystal structure of the protein-kinase a catalytic subunit from criteculus griseus in complex with compound…”. X-ray diffraction, 1 ligand (RIP), 3 pockets (best druggability…

PDB
5NTJ
Type
protein
Length
368 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp-dependent protein kinase catalytic subunit alpha; Camp-dependent protein kinase…
EC
2.7.11.11
UniProt
P25321, A0A061IH64
Ligands
RIP
Pockets
3 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACamp-dependent protein kinase catalytic subunit alpha (EC 2.7.11.11)protein35039% helix, 15% strandP25321
BCamp-dependent protein kinase inhibitorprotein1839% helix, 0% strandA0A061IH64

Ligands and binding sites

  • RIP · beta-D-ribopyranose · ligand · chains A, B
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17100.700.7749empty
22560.590.7932MPD
3640.280.7315empty

Interfaces

1 interface between chains.

  • A–B · 746 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified, 1 covalent (phosphorylation, covalent ligand).

Compared structures

  • 5NTJ · Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.